Aug 07, 2020
FDA approves oral treatment for spinal muscular atrophy
First drug for spinal muscular atrophy that can be taken orally, providing an important treatment option for patients with this disease.
Jun 19, 2020
CDC reports a novel strain of antibiotic-resistant meningitis
CDC issues new recommendation for treatment of deadly meningitis.
Mar 26, 2020
COVID-19 Neurology Resources
Stay up-to-date with the latest information and resources for clinicians during the COVID-19 crisis.
Mar 04, 2020
FDA takes rare step to ban electrical stimulation devices for self-injurious or aggressive behavior
Devices found to present unreasonable and substantial risk of illness or injury.
Dec 19, 2019
Nerve drugs gabapentin, pregabalin linked to breathing problems
The agency will add new warning labels to the drugs.
Nov 22, 2019
FDA approves new treatment for adults with partial-onset seizures
XCOPRI (cenobamate tablets) is a new option to treat adults with partial-onset seizures.
Oct 30, 2019
FDA approves diroximel fumarate for relapsing forms of multiple sclerosis
Drug is a novel oral fumarate with a distinct chemical structure that is designed to impact its gastrointestinal tolerability.
Oct 24, 2019
FDA Approves Botox for Lower-Limb Spasticity in Children
Approval marks onabotulinumtoxinA’s 11th therapeutic indication.
Oct 11, 2019
FDA approves new treatment for patients with migraine
New drug approved for treatment of migraine with or without aura in adults.
Aug 28, 2019
FDA approves new add-on drug to treat off episodes in adults with Parkinson disease
Patients treated with drug experienced statistically significant decrease from baseline in daily “off” time.